Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Lilly Icos presents new PDE5 inhibitors for male and female sexual dysfunction

Dec. 9, 2002

Marketing authorization application submitted for Striant in U.K.

Dec. 9, 2002

ZP-120 completes phase I trial

Dec. 9, 2002

Kissei licenses KUC-7483 to Boehringer Ingelheim

Dec. 2, 2002

Ortho Biotech licenses bone morphogenetic protein technology

Nov. 29, 2002

Effective agents for nephritis without cardiovascular side effects designed at Tanabe Seiyaku

Nov. 28, 2002

Renoprotective effects of ALT-711 in diabetic rats

Nov. 27, 2002

Potential use of pirfenidone in progressive renal disease

Nov. 27, 2002

Positive opinion for Levitra in E.U.

Nov. 26, 2002

FDA requests additional animal study before lifting Vasomax clinical hold

Nov. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...